Actively Recruiting
Study of How Bivalirudin Medicine Acts in Children Undergoing Heart Procedures or Support Devices
Led by Boston Children's Hospital · Updated on 2025-07-02
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how the drug bivalirudin behaves in the blood of pediatric patients needing blood thinning during heart procedures. This includes children undergoing cardiac catheterization, heart surgery with cardiopulmonary bypass CPB, or using life support devices such as extracorporeal membrane oxygenation ECMO or ventricular assist devices VAD. The goal is to understand the drugs levels and effects in these specific medical situations. The study observes children who already require bivalirudin as part of their care. Dosing varies by procedure for CPB, an initial intravenous dose is given 10 minutes before bypass, followed by a continuous infusion, with extra doses if needed. During cardiac catheterization, a bolus dose is followed by an infusion for the procedures duration. For ECMO or VAD support, dosing follows hospital guidelines but is tailored by the care team. The study does not assign treatments but monitors these real-world uses. Participants will have their blood tested to measure bivalirudin levels during treatment and for a short time after stopping the drug, varying by procedure length. Researchers will also track blood clotting problems, unexpected bleeding, and survival continuously during treatment and up to one year after enrollment. The study involves ongoing monitoring while in the hospital and long-term follow-up to assess safety and drug behavior over time.
CONDITIONS
Brief Title
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
Research Team
Z
Zaleski L Zaleski, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here